Lakefront Biotherapeutics NV (GXE.STU) Q2 2026 Earnings

6MayConfirmed
Q2 2026
-0.8
-0.47
-0.13
0.21

Details

Expected EPS
-0.80138023758259
Actual EPS
0.2064761727
Surprise EPS
1.01
Surprise Percent
+125.77%

Description

Lakefront Biotherapeutics NV (GXE.STU) has reported earnings of 0.2064761727 per share for Q2 2026.

0 Comments

Share your thoughts